de Beer VJ, de Graaff HJ, Hoekstra M, Duncker DJ, Merkus D. Integrated control of pulmonary vascular tone by endothelin and angiotensin II in exercising swine depends on gender. Am J Physiol Heart Circ Physiol 298: H1976 -H1985, 2010. First published March 26, 2010 doi:10.1152/ajpheart.00459.2009The lungs are now recognized as an active metabolic organ that is a major determinant of the plasma concentrations of the vasoconstrictors endothelin (ET) and ANG II. Several studies have suggested a complex interaction between ET and ANG II in the systemic and coronary vascular beds that is different at rest and during exercise. To date, the interaction between these vasoconstrictor peptides has barely been investigated in relation to the pulmonary vascular bed. Consequently, we investigated the integrated control of pulmonary vasomotor tone by ET and ANG II in 24 chronically instrumented swine (15 female and 9 male) at rest and during graded treadmill exercise. In the systemic circulation, ANG II type 1 (AT1) receptor blockade with irbesartan and mixed ET A/ETB blockade with tezosentan each produced vasodilation. The systemic vasodilator effect of ETA/ETB blockade was enhanced after AT1 blockade in female swine, whereas a trend toward an increase was observed in male swine. In the pulmonary circulation, AT1 receptor blockade had no effect on pulmonary vascular tone in male swine, whereas it resulted in an unexpected increase in pulmonary vasomotor tone in female swine. ETA/ETB receptor blockade did not result in a decrease in pulmonary vasomotor tone at rest but produced a decrease in vasomotor tone during exercise in both genders. This pulmonary vasodilation by ETA/ETB receptor blockade was enhanced after prior AT1 blockade in female swine but not in male swine. In conclusion, in both the systemic and pulmonary circulation of female swine, ANG II inhibits the vasoconstrictor influence of ET. This interaction is gender specific. The observation that plasma ET levels were not altered by AT1 blockade in either gender suggests that the interaction between these vasoconstrictors occurs locally in the vasculature. microcirculation; exercise DURING EXERCISE, systemic vascular resistance (SVR) decreases by 70 -80% as a result of vasodilation of the exercising skeletal muscle. In contrast to the substantial decrease in SVR, pulmonary vascular resistance (PVR) decreases only modestly (20 -40%) during exercise (20). Consequently, the marked increase in cardiac output together with a small increase in left atrial pressure results in a significant increase in pulmonary arterial pressure, which serves to increase the homogeneity of pulmonary perfusion during exercise, thereby improving lung gas exchange (20, 29) . In addition to its obvious role in gas exchange, the lungs are increasingly recognized as an active metabolic organ contributing to the production and degradation of many vasoactive peptides. Two of such peptides that are produced and/or metabolized by the lungs are endothelin (ET) and ANG II. ET B receptors in the lungs mediate the clearance of plasma ET (33). Furthermore, the lungs are the major site for the conversion of inactive ANG I into vasoactive ANG II (34). Although the role of the lungs in determining the plasma concentrations of these peptides is thus well established (20), the role of these peptides in the regulation of pulmonary vascular tone, in particular during exercise, remains incompletely understood. We (22) have previously shown that the pulmonary vasoconstrictor influence of endogenous ET increases during exercise. In contrast, Clair et al. (3) showed that ANG II type 1 (AT 1 ) receptor blockade did not alter either pulmonary artery pressure or PVR at rest or during exercise. This is an intriguing finding given the observation that progressive infusions of ANG II induce pulmonary vasoconstriction and that this effect of ANG II is even larger in the pulmonary circulation than in the systemic circulation (17).
The lungs are now recognized as an active metabolic organ that is a major determinant of the plasma concentrations of the vasoconstrictors endothelin (ET) and ANG II. Several studies have suggested a complex interaction between ET and ANG II in the systemic and coronary vascular beds that is different at rest and during exercise. To date, the interaction between these vasoconstrictor peptides has barely been investigated in relation to the pulmonary vascular bed. Consequently, we investigated the integrated control of pulmonary vasomotor tone by ET and ANG II in 24 chronically instrumented swine (15 female and 9 male) at rest and during graded treadmill exercise. In the systemic circulation, ANG II type 1 (AT1) receptor blockade with irbesartan and mixed ET A/ETB blockade with tezosentan each produced vasodilation. The systemic vasodilator effect of ETA/ETB blockade was enhanced after AT1 blockade in female swine, whereas a trend toward an increase was observed in male swine. In the pulmonary circulation, AT1 receptor blockade had no effect on pulmonary vascular tone in male swine, whereas it resulted in an unexpected increase in pulmonary vasomotor tone in female swine. ETA/ETB receptor blockade did not result in a decrease in pulmonary vasomotor tone at rest but produced a decrease in vasomotor tone during exercise in both genders. This pulmonary vasodilation by ETA/ETB receptor blockade was enhanced after prior AT1 blockade in female swine but not in male swine. In conclusion, in both the systemic and pulmonary circulation of female swine, ANG II inhibits the vasoconstrictor influence of ET. This interaction is gender specific. The observation that plasma ET levels were not altered by AT1 blockade in either gender suggests that the interaction between these vasoconstrictors occurs locally in the vasculature. microcirculation; exercise DURING EXERCISE, systemic vascular resistance (SVR) decreases by 70 -80% as a result of vasodilation of the exercising skeletal muscle. In contrast to the substantial decrease in SVR, pulmonary vascular resistance (PVR) decreases only modestly (20 -40%) during exercise (20) . Consequently, the marked increase in cardiac output together with a small increase in left atrial pressure results in a significant increase in pulmonary arterial pressure, which serves to increase the homogeneity of pulmonary perfusion during exercise, thereby improving lung gas exchange (20, 29) . In addition to its obvious role in gas exchange, the lungs are increasingly recognized as an active metabolic organ contributing to the production and degradation of many vasoactive peptides. Two of such peptides that are produced and/or metabolized by the lungs are endothelin (ET) and ANG II. ET B receptors in the lungs mediate the clearance of plasma ET (33) . Furthermore, the lungs are the major site for the conversion of inactive ANG I into vasoactive ANG II (34) . Although the role of the lungs in determining the plasma concentrations of these peptides is thus well established (20) , the role of these peptides in the regulation of pulmonary vascular tone, in particular during exercise, remains incompletely understood. We (22) have previously shown that the pulmonary vasoconstrictor influence of endogenous ET increases during exercise. In contrast, Clair et al. (3) showed that ANG II type 1 (AT 1 ) receptor blockade did not alter either pulmonary artery pressure or PVR at rest or during exercise. This is an intriguing finding given the observation that progressive infusions of ANG II induce pulmonary vasoconstriction and that this effect of ANG II is even larger in the pulmonary circulation than in the systemic circulation (17) .
To date, no study has investigated the integrated control of pulmonary vascular tone by ANG II and ET. This is important as the ET and ANG II systems have been shown to interact in a variety of experimental model systems. For example, ET has been shown to facilitate the conversion of ANG I into ANG II in rat pulmonary artery endothelial cells in vitro (14) . Conversely, ANG II has been shown to increase prepro-ET mRNA levels in rat aorta vascular smooth muscle cells in vitro (9, 11) , while the intrapericardial infusion of ANG II stimulated big ET-1 production in the in vivo dog heart (37) . Taken together, these observations suggest a synergistic action between ET and ANG II. In contrast to the ET-stimulating effects of exogenous ANG II, endogenous ANG II appears to suppress the ET system. Thus, in anesthetized rats (31) and dogs (8) , combined blockade of ET A /ET B and AT 1 receptors resulted in a decrease in SVR that was larger than the sum of the decreases in SVR produced by individual ET A /ET B and AT 1 blockade. These observations could be interpreted to suggest that the lack of effect of AT 1 blockade on PVR previously reported in swine (3) and dogs (8) may have been due to a concomitant increased ET vasoconstrictor influence.
Pulmonary arterial hypertension is accompanied by an increase in PVR, which is mediated in part by an increased vasoconstrictor influence of ET (19, 20) . Although this disease is more common in women compared with men (19) , very little is known about the gender differences in neurohumoral control of the pulmonary vasculature. Given the observations that estrogen has been shown to decrease AT 1 gene expression in the systemic circulation of rats (26) and that exogenous ANG II causes more hypertension in male mice compared with female mice (40) , it is likely that gender affects the neurohumoral control of the pulmonary vasculature.
In light of these considerations, we investigated the integrated influences of endogenous ANG II and ET as well as the influence of gender on pulmonary vascular control. For this purpose, we investigated the effects of the AT 1 receptor blocker irbesartan on pulmonary vascular tone in chronically instrumented swine. To determine whether AT 1 receptor blockade modifies the pulmonary vasoconstrictor influence of endogenous ET, we studied the effects of the mixed ET A /ET B receptor blocker tezosentan in both the absence and presence of AT 1 receptor blockade. Since the effects of endogenous ET on PVR are most pronounced during exercise (22), we studied swine both at rest and during graded treadmill exercise.
METHODS

Animals
This study was performed in accordance with the Council of Europe Convention (ETS123)/Directive (86/609/EEC) for the protection of vertebrate animals used for experimental and other scientific purposes and with approval of the Animal Care Committee of the Erasmus Medical Center. A total of 26 Yorkshire ϫ Landrace swine [2-3 mo old, 16 female (22 Ϯ 1 kg) and 10 neutered male (21 Ϯ 1 kg)] entered the study.
Surgery
Swine were sedated (20 mg/kg im ketamine and 1 mg/kg im midazolam), anesthetized (15 mg/kg iv thiopental sodium), intubated, and ventilated with a mixture of O 2 and N2O (1:2) to which 0.2-1.0% (vol/vol) isoflurane was added (5) . Anesthesia was maintained with midazolam (2 mg/kg iv) and fentanyl (10 g·kg Ϫ1 ·h Ϫ1 iv). Swine were instrumented under sterile conditions as previously described (13, 22) . Briefly, a thoracotomy was performed in the third intercostal space. Subsequently, polyvinylchloride catheters were inserted into the aortic arch, left atrium, and pulmonary artery for the measurement of pressures. Furthermore, these catheters were used for arterial and mixed venous blood sampling to determine PO 2, PCO2, and pH (ABL 505, Radiometer) and oxygen saturation and hemoglobin concentration (OSM3, Radiometer) as well as for the infusion of drugs. A Transonic flow probe was implanted around the ascending aorta for the measurement of cardiac output. All catheters were tunnelled subcutaneously to the back. The chest was closed, and animals were allowed to recover. Animals received analgesia (0.3 mg im buprenorphine) for 2 days and antibiotic prophylaxis (25 mg/kg iv amoxicillin and 5 mg/kg iv gentamycin) for 5 days. One male and one female pig died overnight after surgery.
Experimental Protocols
Experiments were performed ϳ2 wk after surgery on 2 different days and in random order.
ET. With swine [8 female (26 Ϯ 1 kg) and 7 male (26 Ϯ 1 kg)] lying quietly on the treadmill, resting hemodynamic measurements were obtained and blood samples were collected. Hemodynamic measurements were repeated, and rectal temperatures were measured with animals standing on the treadmill. Subsequently, a five-stage (1-5 km/h) treadmill exercise protocol was started; each exercise stage lasted 2-3 min. Hemodynamic variables were continuously recorded, and blood samples were collected during the last 45 s of each stage. After completing the control exercise protocol, animals were allowed to rest on the treadmill for 90 min.
The mixed ET A/ETB antagonist tezosentan (a gift from Actelion Pharmaceuticals, Allschwil, Switzerland) was then infused intravenously in a dose of 3 mg/kg followed by an infusion of 6 mg·kg Ϫ1 ·h Ϫ1 iv (22) , and the exercise protocol was repeated. Tezosentan has a pA2 of 9.5 for ETA and a pA2 of 7.7 for ETB receptors, indicating only a 63-fold selectivity for ETA receptors compared with ETB receptors (4, 36) . We (5) have previously shown excellent reproducibility of the hemodynamic response in two consecutive bouts of exercise in swine.
ANG II. On a separate day, 90 min after swine [10 female (28 Ϯ 1 kg) and 6 male (24 Ϯ 1 kg)] had undergone a control exercise trial as described above, the AT 1 receptor antagonist irbesartan (a gift from Bristol-Myers Squibb, dose: 1 mg/kg, dissolved in physiological saline at pH 8) was infused intravenously over a 10-min period, followed by 5-min of stabilization, before the second exercise trial. Irbesartan is a highly selective AT 1 receptor blocker with an IC50 of ϳ1 nM for the AT1 receptor and an IC50 of 10 M for the AT2 receptor (2) .
ANG II and ET. In a subgroup of swine [5 female (30 Ϯ 2 kg) and 5 male (25 Ϯ 1 kg)] that had undergone the irbesartan exercise trial as described above, a combined intravenous infusion of both irbesartan and tezosentan was performed. Irbesartan (0.5 mg/kg) was infused intravenously over a 5-min period before the exercise trial. Tezosentan was administered simultaneously over a 10-min period (3 mg/kg) followed by an infusion of 6 mg·kg Ϫ1 ·h
Ϫ1
, and the exercise protocol was repeated.
Data Analysis
The digital recording and off-line analysis of hemodynamic data have been described in detail elsewhere (5, 22) . Body O2 consumption was computed as the product of cardiac output and the arteriovenous oxygen content difference. Pulmonary vascular conductance (PVC) and systemic vascular conductance (SVC) were calculated as cardiac output divided by pulmonary artery pressure minus left atrial pressure and cardiac output divided by mean aortic pressure, respectively. PVR and SVR were calculated as 1/conductance. To accommodate for the varying weights between animals and groups cardiac output, body O 2 consumption, PVC, PVR, SVC, and SVR were indexed to body weight. ET-1 plasma levels were determined as previously described (21, 23) .
Statistical Analysis
The statistical analysis of hemodynamic data was performed using one-way (exercise), two-way (gender and exercise), or three-way (drug treatment, gender, and exercise) ANOVA for repeated measures. When significant effects were detected, post hoc testing for the effects of exercise and drug treatment was performed using Scheffé's test. To test for the effects of drug treatment on the relation between body O 2 consumption and SVC or PVC, regression analysis was performed with each animal as a dummy variable and with drug treatment, gender, and body O 2 consumption (a measure for exercise) as independent variables. Statistical significance was accepted at P Յ 0.05 (two tailed). Data are presented as means Ϯ SE.
RESULTS
Systemic Circulation
Graded treadmill exercise resulted in more than a doubling of cardiac output, which was principally the result of an increase in heart rate (up to 85% of maximum), as stroke volume increased by only 15%. The increase in cardiac output was balanced by a similar degree of systemic vasodilation, i.e., a ϳ55% decrease in SVR or a ϳ125% increase in SVC ( Fig. 1) , so that mean aortic pressure was minimally affected (Table 1) . Gender did not affect these systemic hemodynamic responses to exercise.
Exercise had no effect on arterial O 2 saturation but was accompanied by a progressive decrease in mixed venous O 2 saturation (Table 2) . Conversely, exercise caused a decrease in arterial PCO 2 (reflecting mild hyperventilation), whereas mixed venous PCO 2 was essentially maintained. The increase in O 2 extraction (reflected by the arteriovenous O 2 content difference) was slightly higher in male swine compared with female swine particularly at rest (Table 2 ) and during submaximal exercise up to 3 km/h (data not shown). The increased O 2 extraction together with the increase in cardiac output enabled a quadrupling of whole body O 2 consumption in both genders.
For similar levels of exercise, body O 2 consumption was slightly higher in male swine compared with female swine. However, the relations between body O 2 consumption and SVR, SVC, PVR, and PVC were not affected by gender (Fig. 1) .
The AT 1 receptor antagonist irbesartan produced a small decrease in mean aortic pressure, whereas heart rate was minimally affected, and cardiac output increased slightly (Table 1). These observations imply that systemic vasodilation occurred. Indeed, SVC increased as a result of AT 1 receptor antagonism (Fig. 2) . Moreover, the increase in SVC was slightly larger in male swine compared with female swine.
The mixed ET A /ET B receptor antagonist tezosentan also resulted in a decrease in mean aortic pressure, which was accompanied by a small, presumably baroreceptor-mediated, increase in heart rate and cardiac output both at rest and during exercise (Table 1) . Hence, SVC increased, implying systemic vasodilation (Fig. 2) . The systemic vasodilation induced by tezosentan was similar in male and female swine.
The administration of tezosentan to male swine pretreated with irbesartan produced similar systemic hemodynamic alterations as tezosentan administered under control conditions (Table 1 and Fig. 2) , although there was a trend (P ϭ 0.09) toward an increased vasodilator effect. In female swine, the tezosentan-induced vasodilation was significantly larger after irbesartan compared with control conditions, particularly during exercise. Irbesartan and tezosentan had no effect on arterial blood gases but produced small increases in mixed venous O 2 saturation (Table 2) , reflecting the increased O 2 delivery due to systemic vasodilation.
Altogether, our data indicate that endogenous ANG II acts to suppress the ET system in the systemic vasculature.
Pulmonary Circulation
Exercise resulted in an increase in pulmonary artery pressure (Table 1) . However, the transpulmonary pressure gradient (pulmonary artery pressure minus left atrial pressure) increased slightly less than cardiac output, reflecting a small degree of exercise-induced pulmonary vasodilation in both genders (Fig. 1) .
AT 1 receptor blockade with irbesartan did not result in statistically significant changes in pulmonary artery pressure and left atrial pressure. Irbesartan had no effect on pulmonary vascular tone in male swine but produced a small unexpected decrease in PVC in female swine at rest and during treadmill exercise, reflecting pulmonary vasoconstriction (Fig. 3) . In accordance with a previous study (22) from our laboratory, the infusion of tezosentan had very little effect on pulmonary hemodynamics under resting conditions. In contrast, during exercise, tezosentan reduced pulmonary artery pressure, with no effect on left atrial pressure, whereas cardiac output slightly increased (Table 1) . Thus, tezosentan resulted in a progressive increase in PVC with increasing exercise intensity, implying pulmonary vasodilation (Fig. 3) . The effects of tezosentan on the pulmonary vasculature were independent of gender.
In the presence of irbesartan, the tezosentan-induced pulmonary vasodilation was enhanced compared with its effect under control conditions in female, but not male, swine (Fig. 3) . Altogether, our data imply that ANG II has no effect in the pulmonary vasculature of male swine, whereas AT 1 receptor blockade enhances ET-mediated constriction in female swine, suggesting that, similar to the systemic vasculature, ANG II acts to limit ET-induced pulmonary vasoconstriction. 
ET Plasma Levels
Plasma ET levels were not altered during graded treadmill exercise. Similarly, AT 1 receptor blockade had no effect on plasma ET levels, either at rest or during exercise (Table 3) .
DISCUSSION
The main findings of the present study in exercising swine were that in the systemic vasculature, ET A /ET B blockade resulted in vasodilation that was similar for male and female swine. AT 1 receptor blockade resulted in vasodilation that was slightly more pronounced in male swine compared with female swine. Moreover, AT 1 receptor blockade enhanced the response to ET A /ET B receptor blockade.
In the pulmonary vasculature, ET A /ET B blockade resulted in vasodilation during exercise that was similar for male and female swine. Conversely, AT 1 receptor blockade resulted in small degree of pulmonary vasoconstriction and enhanced the vasodilator response to ET A /ET B blockade in female, but not male, swine. The implications of these findings will be discussed below.
Methodological Considerations
Determination of PVC. PVC is defined as cardiac output divided by mean pulmonary pressure minus mean pulmonary back pressure. In experimental studies (20, 29) , both pulmonary wedge pressure and left atrial pressure have been used as measures for pulmonary backpressure. In clinical practice, 
Values are means Ϯ SE; n ϭ 24 swine (15 female and 9 male). Cardiac output and stroke volume were indexed to body weight. *P Ͻ 0.05 vs. rest; †P Ͻ 0.05 vs. corresponding control; ‡P Ͻ 0.05 vs. corresponding irbesartan treatment; §P Ͻ 0.05, male vs. female swine. pulmonary wedge pressure is the "gold standard" for the measurement of pulmonary backpressure, which is mainly due to the fact that it can be easily obtained with the same catheter that is used to measure pulmonary artery pressure. Upon inflation and wedging of the balloon, the pulmonary vasculature distal to the balloon will be emptied, until pressure immediately distal to the balloon equals backpressure and flow stops. It is therefore important to allow sufficient time for pressure to stabilize to prevent the overestimation of wedge pressure (30) . In contrast, direct measurement of left atrial pressure circumvents these potential problems associated with the measurement of wedge pressure and allows the continuous assessment of PVC. Consequently, in the present study, we used mean left atrial pressure as a measure for pulmonary backpres- sure. Importantly, at comparable levels of heart rate, left atrial pressure measurements (Refs. 5 and 35 and the present study) correspond very well with wedge pressure measurements both at rest and during exercise in swine [4 mmHg at rest and increasing to 11 mmHg during exercise (12) ], suggesting that either measurement provides a good estimate of pulmonary backpressure.
Mixed venous PCO2, mmHg
Conductance versus resistance. In general, changes in vasomotor tone of a given vascular bed are extrapolated from changes in either the conductance or resistance of the vascular bed. Although these measures are mathematically related, conclusions can differ markedly depending on the choice of resistance or conductance (27) . Vascular conductance is calculated as flow corrected for pressure (flow/pressure), whereas vascular resistance is calculated as pressure divided by flow. These variables are interchangeable if one investigates the effect of only a single stimulus (i.e., exercise); however, in the present, we studied the effects of vasoconstrictor mechanisms at rest and during various levels of treadmill exercise in the systemic and pulmonary circulations.
The systemic circulation is a system with a low-flow state (high resistance and low conductance) at rest, which transforms into a high-flow state (low resistance and high conductance) during exercise. Consequently, under low-flow conditions at rest, vasodilation causes a large decrease in resistance while the increase in conductance is small (Fig. 4) . In contrast, the same vasodilation under high-flow conditions during exercise causes a large increase in conductance, with only a small decrease in resistance. When quantifying the magnitude of the vasodilator responses, it appears in terms of conductance that a much greater vasodilation occurs during exercise, whereas in terms of resistance it appears that a much greater vasodilation occurs at rest (Fig. 4) . Hence, the increase in SVC produced, for example, by ET A /ET B blockade in the presence of AT 1 blockade increased progressively with incremental levels of exercise (from 2.3 Ϯ 0.2 to 2.6 Ϯ 0.2 ml·min Ϫ1 ·kg Ϫ1 ·mmHg Ϫ1 at rest and from 4.5 Ϯ 0.3 to 5.2 Ϯ 0.3 ml·min Ϫ1 ·kg Ϫ1 ·mmHg
Ϫ1
during maximal exercise), whereas the decrease in vascular resistance tended to wane at higher levels of exercise (from 455 Ϯ 31 to 400 Ϯ 22 mmHg·l Ϫ1 ·min·kg at rest and from 229 Ϯ 15 to 200 Ϯ 12 mmHg·l Ϫ1 ·min·kg during maximal exercise). Interpretation of vasomotor control thus critically depends on the variable used. It has been forwarded that the variable (flow or pressure) that undergoes the primary change should be in the numerator of the index for vascular responses (16) . Since aortic blood pressure remains relatively constant while cardiac output markedly increases during exercise, the most appropriate measure for systemic vascular responses is SVC (cardiac output/aortic blood pressure). An additional argument to use conductance to determine systemic vascular responses is that the systemic circulation is composed of vascular beds of various organs that are perfused principally in parallel. Parallel resistors add reciprocally, whereas parallel conductors add linearly, so that a change in conductance of one regional vascular bed results in an equal change of the total SVC.
The choice for either PVR or PVC as a measure of pulmonary vasomotor tone is less obvious as exercise increases both cardiac output and pulmonary artery pressure (Table 1) . However, the choice for either PVR or PVC also appears less critical, because exercise-induced changes in PVR and PVC are relatively minor compared with the vasodilation caused by tezosentan in the presence of irbesartan (Fig. 4) . Consequently, the use of either resistance or conductance to assess the pulmonary vascular effects of AT 1 and/or ET a /ET B blockade will yield similar interpretations regarding the changes in vasoconstrictor influence of ANG II and ET in the pulmonary bed.
Integrated Regulation of Resistance Vessel Tone by ET and ANG II
Systemic vasculature. AT 1 receptor antagonism resulted in systemic vasodilation at rest and during exercise in both female and male swine; however, the degree of vasodilation was slightly larger in male swine. These data are in accordance with previous observations that the exogenous administration of ANG II results in a larger increase in blood pressure in male mice compared with female mice (40) and that AT 1 receptor mRNA (26, 32) and protein expression (26) are higher in the systemic vasculature of male rats compared with female rats. Altogether, these data indicate that the vasoconstrictor effects of both endogenous and exogenous ANG II are more pronounced in the systemic vasculature of male subjects compared with female subjects.
Little is known about the effects of gender on the ET system. In the present study, blockade of endogenous ET resulted in vasodilation under resting conditions, as reflected by a decrease in blood pressure and increase in SVC that was similar in male and female swine. The increase in SVC produced by ET A /ET B blockade was slightly enhanced during exercise, independent of gender. In female swine, the systemic vasodilator effects of ET A /ET B blockade were significantly enhanced by prior AT 1 blockade, whereas in male swine a trend toward increased vasodilation was observed. Therefore, our data suggest that an increased vasoconstrictor effect of ET limits the systemic vasodilation induced by AT 1 blockade. These observations are corroborated by findings in dogs of either sex (8) and male rats (31) , in which combined blockade of ET A /ET B and AT 1 receptors resulted in decreases in SVR and aortic blood pressure that were larger than the sum of the decreases produced by individual blockade of either ET A /ET B or AT 1 receptors alone. Interestingly, the decreases in blood pressure induced by combined blockade ET A /ET B or AT 1 receptors in these studies are larger than those observed in the present study, which may have been due to the presence of pentobarbital anesthesia. Pentobarbital anesthesia is known to suppress the baroreceptor reflex (39) and influence vasomotor control mechanisms (10, 38) , which may have contributed to the exacerbated decrease in blood pressure in response to combined ET A /ET B and AT 1 receptor blockade. Nevertheless, all studies performed to date show that the hypotensive and vasodilator effect of combined blockade of the ET A /ET B and AT 1 receptors is larger than that of blocking either ET A /ET B or Values are means Ϯ SE (in pg/ml); n ϭ 6 swine (4 female and 2 male). Irbesartan had no effect on plasma endothelin levels (P Ͼ 0.20). Fig. 4 . Effects of drug-induced vasodilation at rest and during exercise. Shown are the effects of tezosentan in the presence of irbesartan on resistance (R) and conductance (C) of the pulmonary and systemic vascular beds at rest and during exercise (ex) in 10 swine from both sexes (5 female and 5 male). At rest, the effects of tezosentan on SVR were greater than during exercise (⌬Rrest Ͼ ⌬Rex). The opposite was true for SVC (⌬Cex Ͼ ⌬Crest). In the pulmonary circulation, the effects of tezosentan on either resistance or conductance are similar at rest and during exercise.
AT 1 receptors alone, indicating that combined blockade could have added benefit in patients with hypertension (18) .
Pulmonary vasculature. During exercise, there is a small but progressive increase in PVC, reflecting pulmonary vasodilation (20, 29) . This pulmonary vasodilation during exercise blunts the exercise-induced increase in right ventricular afterload. Since right ventricular afterload is a determinant of exercise capacity (7), exercise-induced pulmonary vasodilation likely enhances exercise capacity. However, excess pulmonary vasodilation may result in an increase in pulmonary capillary pressure, particularly during exercise, when pulmonary venous pressure increases, leading to pulmonary edema. Pulmonary edema hampers gas exchange, in particular oxygen uptake, which would then limit exercise capacity. These disparate effects of pulmonary vasodilation imply that pulmonary vascular tone needs to be carefully balanced to obtain the optimal conditions for exercise and enhance exercise capacity (20, 29) .
In agreement with previous studies (13, 22) from our laboratory, blockade of ET A /ET B receptors with tezosentan had very little effect on the pulmonary vasculature at rest but resulted in a progressive increase in PVC (and thus a decrease in PVR) with incremental exercise levels. The pulmonary vasodilator effects of ET A /ET B receptor blockade were gender independent. The administration of the AT 1 receptor blocker irbesartan resulted in a small, paradoxical, decrease in PVC both at rest and during exercise in female swine but not in male swine. Our findings in male swine correspond well with the study of Clair et al. (3), who, using only male swine, found no effects of AT 1 blockade on the pulmonary vasculature. GomezAlamillo et al. (8) , using dogs of either sex, reported no effect of AT 1 receptor blockade on PVR, although in the latter study a trend toward an increase in PVR and thus a decrease in PVC could be observed. An explanation for this effect could be that, similar to our findings, the female dogs were responsible for the trend toward pulmonary vasoconstriction in this study. The observation in the present study that the pulmonary vasodilator response to mixed ET A /ET B receptor blockade was enhanced after prior AT 1 blockade in female swine suggests that the paradoxical increase in pulmonary vascular tone produced by AT 1 blockade was actually the result of an increased ETmediated pulmonary vasoconstriction. This hypothesis is further supported by the observations in male swine, in which AT 1 blockade had no effect on PVC and did not alter the effect of ET A /ET B blockade.
The mechanism via which AT 1 blockade enhanced ETmediated vasoconstriction in both the systemic and pulmonary circulation of female swine is not readily understood. In view of evidence that endogenous ANG II could suppress the ET system (8, 31), we measured the circulating plasma levels of ET before and after AT 1 receptor blockade. However, AT 1 blockade did not appear to affect plasma ET levels (Table 3) . Although ET secretion occurs predominantly on the abluminal side and plasma levels may therefore not adequately reflect interstitial ET concentrations, these findings point toward an interaction between ET and ANG II at the local vascular receptor level. For example, the approximately fivefold increase in ANG II plasma levels after irbesartan infusion (21) could have resulted in the activation of the AT 4 receptor, which has been shown to cause ET-dependent vasoconstriction in the basilar artery of rats (6) . This is rather unlikely, however, as the activation of the AT 4 receptor on pulmonary endothelial cells has been shown to cause nitric oxide-dependent vasodilation (1) .
Alternatively, since ET and ANG II act in part through the same signaling pathways (15, 24, 25) , it could be speculated that the interaction between endogenous ET and ANG II occurs at the postreceptor level. The colocalization of ET A , ET B , AT 1 , and estrogen receptors in the caveolae (28) may provide an environment in which estrogen can influence the interaction between signaling through ET A /ET B and AT 1 receptors.
Conclusions
The present study shows that endogenous AT 1 receptor activity blunts the vasoconstrictor influence of ET in the pulmonary and systemic circulation of female swine but not male swine. We (13) have previously shown that the vasodilator nitric oxide also markedly attenuates the vasoconstrictor influence of endogenous ET in the pulmonary and systemic circulation during exercise. Taken together, these observations provide evidence for a myriad of vasomotor control mechanisms that act to limit the vasoconstrictor influence of ET and that may, at least in part, be gender dependent. Given the findings in the present study and the larger incidence of pulmonary hypertension in women, studies on the control of pulmonary vascular tone should take gender into account.
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